Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Recs

1
Player Avatar spintousa (59.22) Submitted: 11/7/2006 12:17:24 PM : Outperform Start Price: $42.27 FMS Score: +57.28

Very stable, recession-proof sector no matter what happens with the FOMC.

Featured Broker Partners


Advertisement